Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

MNKD $0.55 0.0700 +14.58%
CASC $5.50 0.5300 +10.66%
BLCM $18.72 1.7400 +10.25%
SYRS $15.47 1.3900 +9.87%
CTIC $0.49 0.0430 +9.73%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

TRIL $6.70 -0.5000 -6.94%
MRTX $5.05 -0.2000 -3.81%
BPMC $27.01 -0.9900 -3.54%
RXDX $5.95 -0.2000 -3.25%
LBIO $6.00 -0.2000 -3.23%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | Next > | Last >>

With Final MACRA Rule, CMS Increases Flexibility

(ACCCBuzz) Oct 17, 2016 - ACCC is conducting an in-depth analysis of the rule; however, an initial look reveals that CMS has heard the stakeholders’ message loud and clear: Make the transition to MACRA as simple and flexible as possible. Here are some top-level highlights from the final rule:
read article 

ASCO Applauds Quality Payment Program’s Focus on High-Quality, Patient-Centered Care

(ASCO in Action) Oct 14, 2016 - “The American Society of Clinical Oncology (ASCO) applauds the Centers for Medicare & Medicaid Services (CMS) for taking a critical step toward transitioning Medicare from volume-based reimbursement to a system that emphasizes high-quality, patient-centered care. In today’s release of the MACRA Quality Payment Program (QPP), CMS has demonstrated welcomed flexibility and choices for clinicians.
read article 

Final MACRA Rule Released; Clinicians Rewarded for High-Quality, Patient-Centered Care

(ASCO in Action) Oct 14, 2016 - The Centers for Medicare & Medicaid Services (CMS) today released the agency's final rule detailing the Quality Payment Program (QPP), which, under the Medicare Access and CHIP Reauthorization Act (MACRA), changes the way physicians are reimbursed for services provided under Medicare Part B.
read article 

Moffitt Cancer Center, UnitedHealthcare Launch New Cancer Care Payment Model

(Moffitt) Oct 17, 2016 - Moffitt Cancer Center and UnitedHealthcare have launched a new payment model for treating lung cancer that focuses on quality patient care and outcomes.
read press release 

Personal Genome Diagnostics Selected to Participate in U.S. Cancer Moonshot Effort to Jump Start Liquid Biopsy Database

(The Business Journals) Oct. 17, 2016 - PGDx joins consortium of public, private and academic innovators developing pilot for a blood profiling atlas to help ensure the validity, utility and accessibility of liquid biopsies for cancer research, diagnosis and treatment.
read article 

Guardant Health Makes Commitment To Share Expertise And Data To Advance Blood Profiling Atlas, Part Of White House Cancer Moonshot

(TheStreet) Oct 17, 2016 - Company will draw from world's largest comprehensive liquid biopsy database to advance goal of creating an open database of cancer genomic profiling information.
read article 

Lilly Partners with the National Cancer Institute to Accelerate Cancer Research through New Program under Cancer Moonshot Initiative

(Lilly) Oct 17, 2016 - New database provides access to oncology studies in an effort to speed medicines to patients.
read corporate press release 

IBM Is Counting on Its Bet on Watson, and Paying Big Money for It

(New York Times) Oct 17, 2016 - IBM is collaborating with Quest Diagnostics, the medical laboratory company, to offer gene sequencing and Watson diagnostic analysis, as a cloud service, to oncologists treating cancer patients, starting on Monday.
read article 

Angiochem's ANG1005 Shows Clinical Benefits and Prolonged Survival for Breast Cancer Patients With Brain Metastases

(Yahoo! Finance) Oct 17, 2016 - Angiochem recently presented data from its Phase II trial for its lead compound, ANG1005, at two highly regarded international cancer conferences: The European Society for Medical Oncology (ESMO) 2016 Congress and the European Association of Neuro-Oncology (EANO) 2016 Meeting.
read article 

Smokeless Tobacco Product Snus May Increase Risk Of Death Among Prostate Cancer Patients

(Harvard T.H. Chan School of Public Health) Oct 12, 2016 - The smokeless tobacco product snus, which is used mainly in Sweden but also is sold in the U.S., may increase the risk that men with prostate cancer will die from their disease, and the risk that they’ll die prematurely from any cause, according to a new study led by researchers at Harvard T.H. Chan School of Public Health.
read press release 

Obesity Ups Risk for Secondary Primary Cancers in Men

(Physician’s Briefing/HealthDay News) Oct 14, 2016 - Higher risk of secondary primary cancer in obese male survivors versus general population.
read article 

Estrogen Signaling Impacted Immune Response in Cancer

(The Wistar Institute) Oct 14, 2016 - While the role of estrogen signaling in tumor development is well understood in breast and ovarian cancer, its role in anti-tumor immunity has not been extensively studied. However, new research from The Wistar Institute showed that estrogen signaling was responsible for immunosuppressive effects in the tumor microenvironment across cancer types.
read press release 

Scientists Develop A New Method To Measure Radiation Dose In Cancer Patients

(LLNL [Livermore, CA]) Oct 13, 2016 - Lawrence Livermore National Laboratory (LLNL) scientists and collaborators have developed a new technique to measure radiation dose levels using gene expression analysis of whole blood from cancer patients receiving targeted radiation therapy.
read news 

Imaging with New Biomarker Tracks Tumor Progression, Response To Treatment For Common Brain Cancer

(UT Southwestern) Oct 13, 2016 – UT Southwestern Medical Center researchers have developed an MRI-based method that can track the state and progression of a common type of genetically mutated brain cancer.
read press release 

Born Rich or Poor? Where You Begin Life Affects Cancer Risk Later

(HCI) Oct 13, 2016 - Researchers at Huntsman Cancer Institute (HCI) at the University of Utah announced today the results of a study that found that circumstances in childhood, such as parental occupation at birth and neighborhood income, may be associated with different risks of certain cancers later in life.
read press release 

Atezolizumab: First PD-L1 Inhibitor for Second-Line NSCLC

(Medscape Medical News) Oct 17, 2016 - A slightly different immunotherapy has shown benefit in the second-line treatment of non–small cell lung cancer (NSCLC).
read article (free registration required) 

FACT SHEET: Vice President Biden Delivers Cancer Moonshot Report, Announces Public and Private Sector Actions to Advance Cancer Moonshot Goals

( of the Vice President) Oct 17, 2016 - Today in the Oval Office, Vice President Joe Biden delivered the Cancer Moonshot report to the President and the American public.
read press release 

Biden’s Final ‘Cancer Moonshot’ Report Outlines Progress and Hurdles

(Washington Post) Oct 17, 2016 - Vice President Biden is expected to tell President Obama on Monday that the administration’s “cancer moonshot” effort infused new urgency in the fight against the disease but that formidable challenges remain, including a lack of coordination among researchers, an “antiquated” funding culture and unacceptably slow dissemination of important information about new treatments.
read article (free registration required) 

White House To Announce Big Push For Cancer Blood Tests

(Forbes) Oct 17, 2016 - The White House, as part of the Cancer Moonshot effort being run by Vice President Joe Biden, is announcing a major push to develop blood tests that can detect and monitor cancer, that aims to unite makers of diagnostic tests, drugs, and other cancer-related products.
read article 

With 20 Agents, 803 Trials, and 166,736 Patient Slots, Is Pharma Investing Too Heavily in PD-1 Drug Development?

(The Cancer Letter) Oct 7, 2016 - Pharmaceutical companies are betting big on cancer immunotherapies that rely on the PD-1 protein and its ligands, PD-L1 and PD-L2, to initiate an immune response.
read article 

NICE to Create Fast Track For Most Cost-Effective New Drugs

(PmLiVE [UK]) Oct 14, 2016 - Patients could get access to some medicines three months faster under a new 'fast track' appraisal process proposed by the UK's National Institute for Health and Care Excellence (NICE).
read article 

HHS Issues Final Rule to Enhance the Reliability, Transparency, Accountability, and Safety of Certified Health Information Technology

( Oct 14, 2016 - Today, the U.S. Department of Health and Human Services’ (HHS) Office of the National Coordinator for Health Information Technology (ONC) issued a final rule that emphasizes the importance of protecting public health and safety while also strengthening transparency and accountability in the ONC Health IT Certification Program (“Program”).
read press release 

HHS Finalizes Streamlined Medicare Payment System That Rewards Clinicians For Quality Patient Care

( Oct 14, 2016 - Today, the Department of Health & Human Services (HHS) finalized a landmark new payment system for Medicare clinicians that will continue the Administration’s progress in reforming how the health care system pays for care.
read press release 

White House Says MACRA Will Ease Into Doctor Practices

(Forbes) Oct 14, 2016 - The Obama administration said today it will allow for ongoing input, comment and “fewer burdens” for physicians from the newly unveiled “MACRA” final rule that ties doctor Medicare payments to quality and outcomes.
read article 

Cedars-Sinai Taps Robert Figlin, MD, To Lead New Initiative To Integrate Cancer Care And Treatment Across Health System

(Cedars-Sinai) Oct 13, 2016 – In an effort to standardize cancer care and ensure optimal treatment of patients, Cedars-Sinai has appointed a prominent oncologist to integrate research and clinical strategies across the organization.
read press release